Budget Impact of the Oncotype DX Breast Recurrence Score Test in Patients with Early Primary Hormone-Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in Germany. Michael Patrick Lux et al. Breast Care (Basel) 2024 19(1) 27-33

https://phgkb.cdc.gov/PHGKB/translationClip.action?action=home